Transvaginal Mesh MDL Update: Jury Awards $2 Million to Plaintiff Against C.R. Bard in First Federal Trial
The first bellwether trial in the Multidistrict Litigation against C.R. Bard, In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation (MDL 2187), has resulted in a $2 million dollar verdict in favor of Plaintiff Donna Cisson, a 55-year old nurse from Georgia who received permanent injuries as a result of a transvaginal mesh device manufactured by C.R. Bard. After finding that C.R. Bard’s Avaulta Plus transvaginal mesh device was defectively designed and that the manufacturers failed to warn her surgeon, the jury awarded $250,000 in compensatory damages and $1.75 million in punitive damages. This first trial took place in the Southern District of West Virginia before The Honorable Judge Joseph R. Goodwin.
This is the first federal case that has been tried against a transvaginal mesh manufacturer and nearly 28,000 cases remain pending in federal court. Thousands of women have experienced complications from these transvaginal mesh devices, such as device erosion, organ perforation, intense pain, inability to have sexual intercourse and infection. Many of these women have been required to undergo multiple revision surgeries. According to a recent report, the United States Food and Drug Administration (FDA) estimates that 300,000 women had pelvic organ prolapse surgery in 2010 and that mesh was used in one third of those procedures.
If you or a loved one has experienced serious injuries as a result of a transvaginal mesh device, contact one of our experienced attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297. We will confidentially evaluate your case for free and without any obligation.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements. The case mentioned does not guarantee and/or predict outcomes in future cases.